NYC and CUPERTINO, Calif., (GLOBE NEWSWIRE) — Tenzing Acquisition Corp., a unique function purchase business included in the Uk Virgin Islands (“Tenzing”) (NASDAQ: TZAC), and Reviva Pharmaceuticals, Inc., a Delaware company (“Reviva”) and a California-based clinical-stage pharmaceutical business developing treatments that address unmet medical requirements into the aspects of nervous system (CNS), cardiovascular, metabolic, and inflammatory conditions, today announced that an exceptional General Meeting of investors of Tenzing (the “Shareholder fulfilling”) to accept the pending company combination between Tenzing and Reviva (the “Business Combination”) is planned become held, Eastern time. Due to COVID-19 limitations on in-person conferences, the Shareholder Meeting will likely to be entirely digital and performed via live webcast.
Tenzing filed its definitive proxy statement/prospectus with regards to the Shareholder fulfilling related to your Business mix (the “Proxy declaration”) using the U.S. Securities and Exchange Commission (the “SEC”) and started mailing it to Tenzing investors. The Proxy Statement is present regarding the SEC internet site. Holders of Tenzing’s ordinary stocks in the close of company regarding the record date have entitlement to notice associated with digital Shareholder Meeting and also to vote during the digital Shareholder Meeting.
Tenzing’s shareholders are expected to read the Proxy declaration, including, on top of other things, the reason why for Tenzing’s Board of Director’s unanimous recommendation that shareholders vote “FOR” the business enterprise mix while the other proposals established when you look at the Proxy Statement.
Tenzing investors whom require support in doing the proxy card, need extra copies for the proxy materials, or have actually questions about the Shareholder Meeting may contact Tenzing’s proxy solicitor, Advantage Proxy, Inc., by phone (cost free) or by e-mail.
About Tenzing Acquisition Corp
Tenzing is just a check that is blank formed for the intended purpose of stepping into a merger, share trade, asset purchase, stock purchase, recapitalization, reorganization or any other comparable company combination with more than one organizations or entities. Tenzing’s efforts to determine a potential target company are not restricted to a specific industry or region that is geographic.
About Reviva Pharmaceuticals, Inc. Reviva Pharmaceuticals, Inc. is just a medical phase pharmaceutical company developing treatments that address unmet medical requirements within the regions of nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva’s main focus is developing its lead item candidate, RP5063 (brilaroxazine), for the treating schizophrenia, manic depression, and major depressive condition. Reviva additionally promises to develop RP5063 for treating PAH and IPF. RP5063 is just a serotonin, dopamine, and nicotinic receptor active ingredient, which includes effectively finished an international period 2 medical test and contains shown medical effectiveness and security for schizophrenia and disorder that is schizoaffective.
Important info in regards to the continuing business blend and how to locate It regarding the the proposed company blend described herein, Tenzing has filed an enrollment declaration on Form S-4 using the SEC, as amended, which became effective (the “Registration Statement”), and which include the Proxy Statement. Tenzing has started mailing the Proxy declaration along with other documents that are relevant each shareholder eligible to vote in the Shareholder Meeting. INVESTORS AND SAFETY HOLDERS ARE ADVISED TO LEARN THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND JUST ABOUT EVERY OTHER RELEVANT PAPERS REGARDING THE THE COMPANY FUSION THAT TENZING HAVE FILED AND CAN FILE AIDED BY THE SEC IF THEY GET AVAILABLE SIMPLY BECAUSE THEY WILL INCLUDE INFORMATION REGARDING TENZING, REVIVA WHILE THE COMPANY COMBINATION. The Registration Statement and Proxy Statement as well as other appropriate materials regarding the the company blend (if they become available), and just about every other papers filed by Tenzing with all the SEC, could be acquired totally free in the SEC’s site or by composing to Tenzing Acquisition Corp. at 250 W. St. that is 55th 13D, New York, NY 10019.
Individuals in Solicitation Tenzing and Reviva and their particular directors, executive officers and workers along with her explanation other individuals might be considered become individuals within the solicitation of proxies through the holders of Tenzing ordinary stocks in respect regarding the proposed company Combination
Information regarding Tenzing’s directors and officers which are executive their ownership of Tenzing’s ordinary stocks is defined forth in Tenzing’s Annual Report on Form 10-K for the year finished filed with all the SEC, as modified or supplemented by any style 3 or Form 4 filed with all the SEC because the date of these filing. Other information about the passions for the individuals when you look at the proxy solicitation is roofed into the Registration Statement and Proxy Statement. These papers can be acquired totally free through the sources suggested above.